{
    "ticker": "NVA",
    "name": "NovaBay Pharmaceuticals, Inc.",
    "description": "NovaBay Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing innovative anti-infective products for the treatment of eye care and other diseases. Founded in 2000 and headquartered in Richmond, California, the company has made significant strides in bringing advanced therapeutic solutions to market. NovaBay is known for its proprietary product, Avenova, which is an FDA-cleared solution designed to help manage blepharitis, a common eyelid condition. Avenova utilizes NovaBay's patented NVC-422 technology, which is based on a novel approach to the treatment of infections. The company is committed to addressing unmet medical needs through its research and development efforts. NovaBay also explores opportunities in other therapeutic areas, leveraging its expertise in anti-infective agents. With a focus on patient care and safety, NovaBay aims to enhance the quality of life for those suffering from chronic eye conditions and infections. The company continually seeks to expand its product pipeline and improve existing therapies, positioning itself as a leader in the ophthalmic market.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Richmond, California, USA",
    "founded": "2000",
    "website": "https://novabay.com",
    "ceo": "Justin Hall",
    "social_media": {
        "twitter": "https://twitter.com/NovaBayPharma",
        "linkedin": "https://www.linkedin.com/company/novabay-pharmaceuticals/"
    },
    "investor_relations": "https://novabay.com/investor-relations/",
    "key_executives": [
        {
            "name": "Justin Hall",
            "position": "CEO"
        },
        {
            "name": "G. Scott Hurd",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Eye Care Products",
            "products": [
                "Avenova"
            ]
        }
    ],
    "seo": {
        "meta_title": "NovaBay Pharmaceuticals, Inc. | Innovative Eye Care Solutions",
        "meta_description": "Discover NovaBay Pharmaceuticals, a leader in anti-infective solutions for eye care. Learn about their innovative products and commitment to improving patient health.",
        "keywords": [
            "NovaBay",
            "Avenova",
            "Eye Care",
            "Biotechnology",
            "Ophthalmic Products"
        ]
    },
    "faq": [
        {
            "question": "What is NovaBay Pharmaceuticals known for?",
            "answer": "NovaBay Pharmaceuticals is known for its innovative anti-infective products, particularly in eye care, with Avenova being its flagship product."
        },
        {
            "question": "Who is the CEO of NovaBay Pharmaceuticals?",
            "answer": "Justin Hall is the CEO of NovaBay Pharmaceuticals, Inc."
        },
        {
            "question": "Where is NovaBay Pharmaceuticals headquartered?",
            "answer": "NovaBay Pharmaceuticals is headquartered in Richmond, California, USA."
        },
        {
            "question": "What products does NovaBay Pharmaceuticals offer?",
            "answer": "NovaBay offers eye care products, with Avenova being a key product for managing eyelid conditions."
        },
        {
            "question": "When was NovaBay Pharmaceuticals founded?",
            "answer": "NovaBay Pharmaceuticals was founded in 2000."
        }
    ],
    "competitors": [
        "EYE",
        "RHEG",
        "RDHL"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX"
    ]
}